Overview
Lunaphore Technologies provides automated, high-throughput platforms like COMET™ for multiplex immunofluorescence (IF) and spatial multiomics analysis, enabling biomarker discovery in immuno-oncology and translational research. Their patented microfluidic chip technology delivers rapid reagent exchange, dynamic incubation, and hyperplex imaging without antibody conjugation, supporting proteomic and transcriptomic data extraction from tissues. As a Bio-Techne brand, they offer integrated solutions with HORIZON™ analysis software and partnerships for AI-driven spatial biology workflows.
Frequently asked questions
- What core technology powers Lunaphore's platforms?
- Lunaphore's patented microfluidic chip enables Fast Fluidic Exchange (FFeX™), dynamic incubation, and controlled reagent delivery for ultra-rapid, reproducible multiplex immunofluorescence and spatial multiomics on the COMET™ platform.
- What applications does COMET™ support?
- COMET™ supports hyperplex IF for immuno-oncology, immunology, neuroscience, and infectious disease research, providing walk-away automation for staining, imaging, and preprocessing with multiomics capabilities for RNA and protein analysis.
- What services and partnerships does Lunaphore offer?
- Lunaphore provides Access Lab for IHC/IF testing, HORIZON™ image analysis software, and partnerships like Discovery Life Sciences for hyperplex services and Visiopharm for AI-powered spatial analysis in cancer research.